[Starlight]

weitere Earnings...


Xilinx quarterly profit rises 2.2%; revenue falls 7.4%

Xilinx Inc. reported first-quarter net earnings of $84.3 million, or 28 cents a share, up 2.2% from $82.5 million, or 24 cents a share, during the year-ago period, said that revenue for the three months ended June 30 fell 7.4% to $445.9 million from $481.4 million in the comparable period last year. Analysts surveyed by Thomson Financial had forecast, on average, a per-share profit of 29 cents on revenue of $453 million.





Polycom 2nd Quarter EPS 11c Versus EPS 17c

Polycom Inc.'s net income declined to $10.08 million, or 11 cents a share, from a year-earlier profit of $15 million, or 17 cents a share. Excluding restructuring expense and other items, net income for the recent period was $28.9 million, or 30 cents a share, compared with $21.9 million, or 24 cents a share, a year earlier.



Capital One quarterly net income jumps 36%

Capital One Financial reported a 36% jump in second-quarter profit late Thursday. Net income came in at $750.4 million, or $1.89 a share, vs. $552.6 million, or $1.78 a share, in the second quarter of 2006, the credit card company said. Capital One also said it expects full-year 2007 earnings to be towards the lower end of a previously announced range of $7 to $7.40 a share.




Cytec Industries 2nd Quarter EPS $1.11 Versus EPS $1


Cytec Industries Inc.'s second-quarter net income rose 13% to $54.8 million, or $1.11 a share, from $48.5 million, or $1 a share, a year earlier on sales growth in the engineered materials unit. Excluding items, earnings were $56.6 million, or $1.15 a share. The West Paterson, N.J., chemical company said net sales rose 1.3% to $864 million from $853.1 million a year ago. On average, analysts polled by Thomson Financial predicted second-quarter earnings of 94 cents a share and revenue of $835.6 million. Analyst estimates typically exclude items. Cytec reaffirmed its 2007 adjusted earnings forecast of $3.60 to $3.80 a share. Analysts predict 2007 net income of $3.65 a share.



Gilead raises 2007 product revenue forecast

Gilead Sciences Inc. late Thursday raised its forecast for full-year 2007 net product revenue to a range of $3.6 billion to $3.7 billion. The biotechnology company had previously said it expected net product revenue would come in between $3.4 billion and $3.5 billion for the period. The raised forecast was issued on a conference call following the release of Gilead's second-quarter results.

After Hours Stand: 23h20